Bio Marker Strategies
Biotechnology, Crabbs Br Way, Rockville, , 20855, Maryland, 15601, United States, 11-50 Employees
Phone Number: 41********
Who is BIOMARKER STRATEGIES
BioMarker Strategies has developed the proprietary SnapPath Cancer Diagnostics System for predictive tests to guide targeted drug development and treatment selection for patients with sol...
Read More
- Headquarters: 15601 Crabbs Br Way, Rockville, Maryland, 20855, United States
- Date Founded: 2007
- Employees: 11-50
- Revenue: $5 Million to $10 Million
- Active Tech Stack: See technologies
- CEO: Jerry Parrott
Industry: Biotechnology
SIC Code: 8069 | NAICS Code: 541720 | Show More
Does something look wrong? Fix it. | View contact records from BIOMARKER STRATEGIES
BioMarker Strategies Org Chart and Mapping
Sign in to CIENCE GO Data to uncover contact details
Free credits every month
Frequently Asked Questions Regarding BioMarker Strategies
Answer: BioMarker Strategies's headquarters are located at Crabbs Br Way, Rockville, , 20855, Maryland, 15601, United States
Answer: BioMarker Strategies's phone number is 41********
Answer: BioMarker Strategies's official website is https://biomarkerstrategies.com
Answer: BioMarker Strategies's revenue is $5 Million to $10 Million
Answer: BioMarker Strategies's SIC: 8069
Answer: BioMarker Strategies's NAICS: 541720
Answer: BioMarker Strategies has 11-50 employees
Answer: BioMarker Strategies is in Biotechnology
Answer: BioMarker Strategies contact info: Phone number: 41******** Website: https://biomarkerstrategies.com
Answer: BioMarker Strategies has developed the proprietary SnapPath Cancer Diagnostics System for predictive tests to guide targeted drug development and treatment selection for patients with solid tumor malignancies. Our mission is to make personalized medicine more of a reality for these patients. SnapPath is unique in automating and standardizing functional ex vivo profiling to capture the dynamic and predictive signaling information available only from live solid tumor cells. Our PathMAP Functional Signaling Profiles, created using the SnapPath system, represent a new class of biomarker tests that are highly predictive of individual response to targeted treatments for solid tumors, because they are based on information available only from live cells. Our business development efforts are directed toward entering into funded collaborations with companies developing targeted therapies for patients with solid tumors. The capabilities of SnapPath and the Functional Profiles it enables are available for Research Use in preclinical studies in tumorgraft and other model systems, and in early clinical studies to assess pharmacodynamic changes in the solid tumors of individual patients.
Premium Sales Data for Prospecting
-
Sales data across over 200M records
-
Up-to-date records (less decayed data)
-
Accurate Email Lists (real-world tested)
-
Powerful search engine and intuitive interface
Sign in to CIENCE GO Data to uncover contact details
Free credits every month